Filing Details
- Accession Number:
- 0001562180-23-008572
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-12-28 16:39:04
- Reporting Period:
- 2023-12-27
- Accepted Time:
- 2023-12-28 16:39:04
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1710072 | Edgewise Therapeutics Inc. | EWTX | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1191702 | R John Moore | C/O Edgewise Therapeutics, Inc. 1715 38Th St Boulder CO 80301 | General Counsel | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2023-12-27 | 8,497 | $10.50 | 0 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Plan adopted by the Reporting Person on June 30, 2023.
- Includes 1,932 shares purchased on May 15, 2023 pursuant to the Edgewise Therapeutics, Inc. 2021 Employee Stock Purchase Plan.
Billionaire Hedge Funds
